CYTR Financial Facts
Research and development: 8.93MGain on warrant derivative liability: 246.21K
See Full Income Statement
Accumulated deficit: -408.19M
Total current assets: 61.6M
See Full Balance Sheet
CytRx Corporation (CYTR) Earnings
|
Expand Research on CYTR
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +4.5% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -5.1% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 8/9/12 | Q212 | -$0.63 | -$0.30 | -$0.33 | N/A | $50M | N/A |  | | Details | |
| 8/3/15 | Q215 | -$0.21 | -$0.27 | +$0.06 | N/A | N/A | N/A | | | Details | |
| 5/11/16 | Q116 | -$0.19 | -$0.26 | +$0.07 | N/A | N/A | N/A | | | Details | |
| 11/4/14 | Q314 | -$0.10 | -$0.25 | +$0.15 | N/A | N/A | N/A | | | Details | |
| 11/3/15 | Q315 | -$0.11 | -$0.24 | +$0.13 | N/A | N/A | N/A | | | Details | |
| 10/29/13 | Q313 | -$0.33 | -$0.22 | -$0.11 | N/A | $200K | N/A | | | Details | |
| 5/1/15 | Q115 | $0.31 | -$0.21 | +$0.52 | N/A | N/A | N/A | | | Details | |
| 8/6/14 | Q214 | -$0.28 | -$0.20 | -$0.08 | N/A | N/A | N/A | | | Details |
